It is good news when researchers gain a little more knowledge about the development of one disease. It is even better news when that little bit of knowledge applies to a whole group of diseases.

In the fight against type 2 diabetes, it is important to know who is at risk for the disease. While obesity is a major part of the picture, genetics also play a role in the development of diabetes.

It's no secret that growing up in poverty has a huge negative impact on children, in many ways. Their education suffers, often because of lower quality schools and the challenges that poverty brings.

Breast cancer that has not begun to spread (metastasize) beyond the original tumor is likely survivable. When the cancer starts to fan out, controlling the disease becomes much more difficult.  Scientists may have pinpointed a way to block this deadly spread.

Pregnant women are often told to take more calcium to benefit themselves and their babies, but the benefits of doing so have been unclear.

When prostate cancer spreads to the bones, it can be very, very painful.  New research shows more effective ways to ease this extreme pain, which can extend the lives of advanced prostate cancer patients and provide researchers insight into how pain relief works.

Testosterone does more than just protect muscle strength and sexual health. In fact, naturally high levels of testosterone may be beneficial to the heart in older men.

The dietary supplement glucosamine is popular for helping aching, arthritic joints. A new supplement looks like it could suppress the damaging autoimmune response seen in multiple sclerosis (MS).

Addiction doesn’t happen the first time around. It takes time for addictions to develop and still many addicts will deny their dependence. When will the denying stop and help be sought out?

The FDA has approved Juvisync, a prescription medication that contains two previously approved medicines in one tablet: Januvia (sitagliptin) for diabetes and Zocor (simvastatin) for high cholesterol.